Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis (LiThuHol)

May 2, 2021 updated by: University Hospital, Angers

Ureteroscopy for Upper Tract Lithiasis : Comparison of Costs and Effectiveness of Both Holmium and Thulium Lasers, in a Prospective Monocentric Study.

Holmium laser is the current gold standard for lithotripsy on urinary lithiasis, while Thulium is brand new. The latter has been released in July 2020 in Europe, and only in-vitro studies have been published.

The aim of this study is to compare the stone free rate in ureteroscopy, for all consecutive patients treated with laser fragmentation, between both Holmium and Thulium lasers.

The costs and complications will also be studied.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who are scheduled for ureteroscopy on renal or ureteral stones, which have been previously confirmed by tomography

Description

Inclusion Criteria:

  • renal ou ureteral stone confirmed by an abdominal and pelvic computed tomography
  • treatment with rigid or flexible ureteroscopy
  • laser lithotripsy during the procedure
  • bacteriological examination of urine (sterile, bacterial colonization or treated by antibiotics)

Exclusion Criteria:

  • non-use of laser for stone lithotripsy
  • pregnant women
  • under 18 years old
  • refusal to give informed consent
  • urinary malformation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Holmium laser lithotripsy
Stone fragmentation are performed with Holmium laser in ureteroscopy
Rigid or flexible ureteroscopy for ureteral or renal stone. Lithotripsy with Holmium laser
Thulium laser lithotripsy
Stone fragmentation are performed with Thulium laser in ureteroscopy
Rigid or flexible ureteroscopy for ureteral or renal stone. Lithotripsy with Thulium laser

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stone free rate
Time Frame: Three months after surgery
Urinary tract echography or renal computer tomography imaging. Patients with residual fragments under 4 mm are stone free.
Three months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perioperative complications
Time Frame: During the intervention
Recording data about ureteric perforation and bleeding
During the intervention
Operating time
Time Frame: Immediately after the intervention
All surgeries are included
Immediately after the intervention
Postoperative complications
Time Frame: Up to three months after surgery
Recording data according to the Clavien classification (rates of hospitalisation, pain, infection and surgical revision)
Up to three months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2021

Primary Completion (Anticipated)

May 1, 2021

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

February 25, 2021

First Submitted That Met QC Criteria

May 2, 2021

First Posted (Actual)

May 4, 2021

Study Record Updates

Last Update Posted (Actual)

May 4, 2021

Last Update Submitted That Met QC Criteria

May 2, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Stone

Clinical Trials on Ureteroscopy for upper tract stone treatment with Holmium laser

Subscribe